Abstracts tagged "Takayasu.s arteritis and pregnancy"

Abstract Number: 3070 • 2015 ACR/ARHP Annual Meeting
Outcome of Pregnancies in Patients with Takayasu Arteritis with Special Focus on Risk Factors and Disease Activity
Noemie Abisror¹, Arsene Mekinian¹, Marc Lambert², Eric Hachulla³, Robin Dhote⁴, Catherine Chapelon⁵, Antoine Néel⁶, Amar Smail⁷, Frederic Vandergheynst⁸, Nihal Martis⁹, Jean Gabriel Fuzibet¹⁰, Françoise Sarrot-Reynauld¹¹, Marc Andre¹², Alain Fur¹³, Francois Maurier¹⁴, Julien Haroche¹⁵, Bertrand Godeau^16,17, Murielle Rondeau¹⁸, Frederic Renou¹⁹, Pauline Belenotti²⁰, Laure Swiader²⁰, Patrice Cacoub²¹, Bruno Devaux²², Luc Mouthon²³, Jean Baptiste Gaultier²⁴, Pascal Cathebras²⁵, Olivier Pourrat²⁶, Olivier Fain¹, Véronique Le Guern²⁷ and Nathalie Costedoat-Chalumeau²⁷, ¹Internal Medicine Department, Saint Antoine Hospital, Paris, France, ²CHU Lille, Lille, France, ³Department of Internal Medicine, University Lille Nord-de-France, Lille, France, ⁴Internal Medicine, Hospital Avicenne, Bobigny, France, ⁵Department of Internal Medicine 2. Referal center for SLE/APS, CHU Pitié-Salpêtrière, Paris, France, ⁶Internal Medicine, Nantes University Hospital, Nantes, France, ⁷Internal Medecine, Amiens Hospital, Amiens, France, ⁸Internal Medicine, Erasme hospital, Bruxelles, Belgium, ⁹Internal medicine, Nice, France, ¹⁰Internal Medicine, Internal Medicine, Hôpital de l'Archet 1, CHU de Nice, Nice, France, ¹¹Internal medicine, Grenoble, France, ¹²Internal medicine, Clermont Ferrand, France, ¹³Internal medicine, Troyes, France, ¹⁴HP Metz Belle Isle Hospital, Department of Internal Medicine, Metz, France, ¹⁵Internal Medecine, Pitié-Salpêtrière hospital, Paris, France, ¹⁶Henri Mondor, Créteil, France, ¹⁷Internal Medicine, University of Paris, AP-HP, Hôpital Mondor Créteil, Creteil, France, ¹⁸Internal medicine, Strasbourg, France, ¹⁹Internal medicine, Saint Denis, France, ²⁰Internal medicine, Marseille, France, ²¹Department of Internal Medicine, Pitié-Salpêtrière Hospital, Paris, France, ²²Internal medicine, Coulommiers, France, ²³Paris Descartes University, UPRES-EA 4058, Department of Internal Medicine, Cochin Hospital, Paris, France, ²⁴Internal medicine, Saint Etienne, France, ²⁵Internal Medicine, University Hospital St Etienne, St Etienne, France, ²⁶Internal medicine, Poitiers, France, ²⁷Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France
Background/Purpose: Takayasu arteritis (TA) is a large-vessel vasculitis that affects young women of childbearing age. We aimed to analyze the outcome of pregnancies in TA…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].